The effect of quetiapine in psychotic Parkinsonian patients with and without dementia. An open-labeled study utilizing a structured interview (Q42664853)

From Wikidata

Jump to navigation Jump to search

scientific article published on 17 August 2005

Language	Label	Description	Also known as
English	The effect of quetiapine in psychotic Parkinsonian patients with and without dementia. An open-labeled study utilizing a structured interview	scientific article published on 17 August 2005

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

The effect of quetiapine in psychotic Parkinsonian patients with and without dementia. An open-labeled study utilizing a structured interview (English)

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

1 reference

based on heuristic

inferred from title

Parkinson's disease

1 reference

based on heuristic

inferred from title

author name string

T Prohorov

1

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

C Klein

2

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

A Miniovitz

3

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

E Dobronevsky

4

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

J M Rabey

5

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

publication date

17 August 2005

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

Journal of Neurology

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

253

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

171-175

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

Predictors of nursing home placement in Parkinson's disease: a population-based, prospective study

1 reference

https://api.crossref.org/works/10.1007%2FS00415-005-0943-4

21 January 2018

Risk of dementia in Parkinson's disease: a community-based, prospective study

1 reference

https://api.crossref.org/works/10.1007%2FS00415-005-0943-4

21 January 2018

Quetiapine for l-dopa-induced psychosis in PD.

1 reference

https://api.crossref.org/works/10.1007%2FS00415-005-0943-4

21 January 2018

Risk factors for nursing home placement in advanced Parkinson's disease

1 reference

https://api.crossref.org/works/10.1007%2FS00415-005-0943-4

21 January 2018

Early dopaminergic drug-induced hallucinations in parkinsonian patients

1 reference

https://api.crossref.org/works/10.1007%2FS00415-005-0943-4

21 January 2018

Low-dose clozapine in the treatment of levodopa-induced mental disturbances in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1007%2FS00415-005-0943-4

21 January 2018

Quetiapine for l-dopa-induced psychosis in PD

1 reference

https://api.crossref.org/works/10.1007%2FS00415-005-0943-4

21 January 2018

1 reference

https://pubmed.ncbi.nlm.nih.gov/16096815

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mental symptoms in Parkinson's disease are important contributors to caregiver distress

1 reference

https://pubmed.ncbi.nlm.nih.gov/16096815

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Psychiatric complications in the treatment of Parkinson's disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/16096815

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Combined effect of age and severity on the risk of dementia in Parkinson's disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/16096815

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clozapine replacement by quetiapine for the treatment of drug-induced psychosis in Parkinson's disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/16096815

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Confusion, dementia and anticholinergics in Parkinson's disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/16096815

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prevalence and clinical correlates of psychotic symptoms in Parkinson disease: a community-based study

1 reference

https://pubmed.ncbi.nlm.nih.gov/16096815

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clozapine-induced agranulocytosis and thrombopenia in a patient with dopaminergic psychosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/16096815

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cognitive deficits in Parkinson's disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/16096815

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mental dysfunction in Parkinson's disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/16096815

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long‐term outcome of quetiapine use for psychosis among parkinsonian patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/16096815

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Quetiapine improves psychotic symptoms and cognition in Parkinson's disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/16096815

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cholinergic correlates of cognitive impairment in Parkinson's disease: comparisons with Alzheimer's disease.

1 reference

https://pubmed.ncbi.nlm.nih.gov/16096815

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The effect of quetiapine on psychosis and motor function in parkinsonian patients with and without dementia

1 reference

https://pubmed.ncbi.nlm.nih.gov/16096815

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Flumazenil, a GABA antagonist, may improve features of Parkinson's disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/16096815

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term evaluation of the effect of quetiapine on hallucinations, delusions and motor function in advanced Parkinson disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/16096815

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The Frequency and Associated Risk Factors for Dementia in Patients With Parkinson's Disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/16096815

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

1 reference

https://pubmed.ncbi.nlm.nih.gov/16096815

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Risperidone in Parkinson's disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/16096815

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clozapine in Parkinson's disease psychosis: 5-year follow-up review

1 reference

https://pubmed.ncbi.nlm.nih.gov/16096815

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Preclinical pharmacology of neuroleptics: focus on new generation compounds.

1 reference

https://pubmed.ncbi.nlm.nih.gov/16096815

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

GPi pallidotomy for Parkinson's disease with drug-induced psychosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/16096815

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy of quetiapine in Parkinson's patients with psychosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/16096815

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Quetiapine as an alternative to clozapine in the treatment of dopamimetic psychosis in patients with Parkinson's disease.

1 reference

https://pubmed.ncbi.nlm.nih.gov/16096815

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Neurologic side effects in neuroleptic-naive patients treated with haloperidol or risperidone

1 reference

https://pubmed.ncbi.nlm.nih.gov/16096815

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Seroquel: biochemical profile of a potential atypical antipsychotic

1 reference

https://pubmed.ncbi.nlm.nih.gov/16096815

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Quetiapine for the treatment of drug-induced psychosis in Parkinson's disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/16096815

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Re: Atypical antipsychotics mechanisms of action

1 reference

https://pubmed.ncbi.nlm.nih.gov/16096815

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Worsening of motor features of parkinsonism with olanzapine

1 reference

https://pubmed.ncbi.nlm.nih.gov/16096815

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00415-005-0943-4

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42664853&oldid=2205592018"